https://orcid.org/0000-0001-8079-520X
Selected Grants
The Post-Lung Transplant Impact of Alveolar Macrophage Senescence in Aged Donor Lungs
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2030Fellowships, Gifts, and Supported Research
Proteomic Guided Predictive Modeling as a Tool for Donor Lung Assessment ·
2026
Awarded by: ISHLT Molecular Biomarker Study Using Artificial Intelligence/Machine Learning Analysis in Lung Transplantation Grant, supported by CareDx
Targeted Ex vivo Nanotherapy for use in Cardiac Transplantation ·
2017
- 2019
Primary Investigator ·
Awarded by: American Heart Association
· $110,456.00
17CPOST3367120. Utilized micellar rapamycin nanoparticles targeted to coronary endothelium during static cold storage to ameliorate ischemia-reperfusion injury post transplantation.
Amelioration of Cardiac Transplant Vasculopathy Using Targeted Ex Vivo Nanotherapy ·
2015
- 2017
T32 Postdoctoral Fellow ·
Awarded by: National Institute of Health; National Heart, Lung, and Blood Institute
· $100,000.00
NIH-HL-007260. Utilized micellar rapamycin nanoparticles targeted to coronary endothelium during static cold storage to delay the onset of chronic rejection and cardiac allograft vasculopathy.